Patent details

EP2572717 Title: PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN

Basic Information

Publication number:
EP2572717
PCT Application Number:
PCT/JP/2011/061376
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117835769
PCT Publication Number:
WO/2011/145642
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN
French Title of Invention:
COMPOSITION PHARMACEUTIQUE CONTENANT DE LA SOLIFÉNACINE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SOLIFENACIN
SPC Number:

Dates

Filing date:
18/05/2011
Grant date:
15/06/2016
EP Publication Date:
15/06/2016
PCT Publication Date:
24/11/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/03/2013
EP B1 Publication Date:
15/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/05/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2016
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, Japan (JP)

Agent

Name:
VALIPAT
From:
21/06/2016
Address:
Avenue Louise 54, 1050, Bruxelles, Belgium (BE)
To:

Inventor

1

Name:
YOSHIOKA Tatsunobu
Address:
Japan (JP)

2

Name:
MURAI Makoto
Address:
Japan (JP)

3

Name:
TASAKI Hiroaki
Address:
Japan (JP)

Priority

Priority Number:
346311 P
Priority Date:
19/05/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4725;

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/05/2025
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
13/03/2026 Request For Change 5
16/03/2026 Outgoing Correspondence 46